Showing results (2061-2070 of 2,127) with videos related to
Sort By:
Pageof 213
Pulmonology|December 15, 2025
From bench to bedside: Exploring the role of sCD25 in melanoma and lung cancer among sleep apnea patientsElena Díaz-García, Enrique Alfaro, Paula Pérez-Moreno, et al.Journal of Neuropathology and Experimental Neurology|April 11, 2012
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literaturePeter T Nelson, Irina Alafuzoff, Eileen H Bigio, et al.Sleep|October 18, 2014
Effectiveness of home single-channel nasal pressure for sleep apnea diagnosisJuan F Masa, Joaquin Duran-Cantolla, Francisco Capote, et al.The American Journal of Surgical Pathology|September 27, 2006
A working group classification of focal prostate atrophy lesionsAngelo M De Marzo, Elizabeth A Platz, Jonathan I Epstein, et al.Molecular Genetics and Metabolism Reports|April 10, 2025
Corrigendum to "Classic and atypical late infantile neuronal ceroid lipofuscinosis in Latin America: Clinical and genetic aspects, and treatment outcome with cerliponase alfa." [Molecular Genetics and Metabolism ReportsVolume 38 (2024) 101060]Norberto Guelbert, Oscar Mauricio Espitia Segura, Carolina Amoretti, et al.Thorax|July 14, 2016
Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoeaJuan F Masa, Jaime Corral, Candela Caballero, et al.Molecular Genetics and Metabolism Reports|March 12, 2024
Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase AlfaNorberto Guelbert, Oscar Mauricio Espitia Segura, Carolina Amoretti, et al.Acta Neuropathologica|October 29, 2014
Primary age-related tauopathy (PART): a common pathology associated with human agingJohn F Crary, John Q Trojanowski, Julie A Schneider, et al.Acta Neuropathologica|May 25, 2026
Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degenerationTimothy E Richardson, Jonathan Cherry, Shrishtee Kandoi, et al.The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.Pageof 213